Catalyst Wire Dossier Catalyst Wire Dossier

MabThera (Rituximab)

rituximab · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for MabThera (Rituximab), covering 2014-08-21 to 2019-03-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status [Phase 4]

See pricing